Enovis Corporation

Enovis Corporation

ENOV

$18.04

Updated: 22/09/2026, 08:43:10

Market Cap
$1.04B
Sector
Healthcare
Industry
Medical - Devices
Country
US
Stock valuation chart
One-year closing share-price history for ENOV
Company Profile

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.

USD
NYSE
CEO: Damien McDonald
Employees: 7,802
https://www.enovis.com
Asset Summaries
Latest generated summaries for ENOV

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for ENOV.
Share price
$18.04
Market cap
$1.04B
Exchange
NYSE
Currency
USD
CEO
Damien McDonald
Employees
7,802
IPO date
08/05/2008
Beta
1.429
Last dividend
$0.00
Day range
$17.47 – $18.04
52-week range
$17.30 – $34.28
1-day performance
0.00%
1-year performance
4.28%
Current drawdown (1Y)
-47.37%
CIK
0001420800
CUSIP
194014502
ISIN
US1940145022
Created
07/12/2025, 03:47:34
Last update
22/09/2026, 08:43:10

Track Enovis Corporation with an AI analyst

See which prediction-market events move ENOV, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.